211-225 of 284
Reducing the ALS Diagnostic Delay: The Impacts of a Rapid Access Clinic
NeuroFrontiersReducing the ALS Diagnostic Delay: The Impacts of a Rapid Access Clinic
Kelly G. Gwathmey, MD
ATTR Peripheral Neuropathy: How to Avoid Misdiagnosis
NeuroFrontiersATTR Peripheral Neuropathy: How to Avoid Misdiagnosis
Morie Gertz, MD, MACP
Advances in IgAN: New Frontiers in Biomarkers and Treatment
On the Frontlines of IgA NephropathyAdvances in IgAN: New Frontiers in Biomarkers and Treatment
Gates B. Colbert, MD
Edward Filippone, MD
Managing High-Risk Myeloma: From Cytogenetic Abnormalities to Therapeutic Approaches
Project Oncology®Managing High-Risk Myeloma: From Cytogenetic Abnormalities to Therapeutic Approaches
Gareth Morgan, MD
Risk Stratification Models for Precursor Diseases in Multiple Myeloma
Project Oncology®Risk Stratification Models for Precursor Diseases in Multiple Myeloma
Betsy O'Donnell, MD
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
Project Oncology®From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
Betsy O'Donnell, MD
- advertisement
Optimizing the Screening of Precursor Diseases in Multiple Myeloma
Project Oncology®Optimizing the Screening of Precursor Diseases in Multiple Myeloma
Betsy O'Donnell, MD
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
NeuroFrontiersComprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
John Brandsema, MD
Continuum of Care: Managing DMD in Pediatric and Adult Patients
NeuroFrontiersContinuum of Care: Managing DMD in Pediatric and Adult Patients
John Brandsema, MD
Optimizing Multiple Myeloma Care: Advances for Newly Diagnosed Patients
Project Oncology®Optimizing Multiple Myeloma Care: Advances for Newly Diagnosed Patients
Morie Gertz, MD, MACP
Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
NeuroFrontiersAdvances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
Charles Turck, PharmD, BCPS, BCCCP
John Brandsema, MD
Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer
Project Oncology®Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer
Matt Birnholz, MD
Saad Kenderian M.B, Ch.B
- advertisement
Gene Therapy Breakthrough in DMD: Insights from the EMBARK Trial
NeuroFrontiersGene Therapy Breakthrough in DMD: Insights from the EMBARK Trial
Uncovering a Potential Biomarker for Myasthenia Gravis
NeuroFrontiersUncovering a Potential Biomarker for Myasthenia Gravis
Developments in DMD Treatment: The First Nonsteroidal Drug Approval
Clinician's RoundtableDevelopments in DMD Treatment: The First Nonsteroidal Drug Approval
